Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Depression × Milnacipran × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Depression 1

Interventions

Therapeutics 31 Psychiatric Rehabilitation 27 Surveys and Questionnaires 15 Cognitive Behavioral Therapy 12 Early Intervention, Educational 10 Psilocybin 9 Ketamine 9 Methods 8 Saline Solution 7 Yoga 6 Mindfulness-Based Cognitive Therapy 6 Interviews as Topic 6 Esketamine 6 Counseling 6 Mindfulness 5 Methylphenidate 5 Escitalopram 5 Educational Status 5 Behavior Therapy 5 Acupuncture Therapy 5 Psychosocial Intervention 4 Palliative Care 4 Exercise Therapy 4 Exercise 4 Control Groups 4 Caregivers 4 Standard of Care 3 Psychotherapy 3 Niacin 3 Mindfulness-Based Stress Reduction 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02783430 2025-12-16

KETAPAL

University Hospital, Lille

Phase 2/3 Completed

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡